Abstract
Baculovirus-based expression of proteins in insect cell cultures has emerged as a powerful technology to produce complex protein biologics for many applications ranging from multiprotein complex structural biology to manufacturing of therapeutic proteins including virus-like particles (VLPs). VLPs are protein assemblies that mimic live viruses but typically do not contain any genetic material, and therefore are safe and attractive alternatives to life attenuated or inactivated viruses for vaccination purposes. MultiBac is an advanced baculovirus expression vector system (BEVS) which consists of an engineered viral genome that can be customized for tailored applications. Here we describe the creation of a MultiBac-based VLP-factory™, based on the M1 capsid protein from influenza, and its application to produce in a parallelized fashion an array of influenza-derived VLPs containing functional mutations in influenza hemagglutinin (HA) thought to modulate the immune response elicited by the VLP.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cox MM, Hollister JR (2000) FluBlok: a next generation influenza vaccine manufactured in insect cells. Biologicals 37(3):182–189
Schiller JT, Lowy DR (2006) Prospects for cervical cancer prevention by human papillomavirus vaccination. Cancer Res 66(21):10229–10232
Temchura V, Überla K (2017) Intrastructural help: improving the HIV-1 envelope antibody response induced by virus-like particle vaccines. Curr Opin HIV AIDS 12(3):272–277
Charlton Hume HK, Lua LH (2017) Platform technologies for modern vaccine manufacturing. Vaccine 35(35 Pt A):4480–4485
Jeong H, Seong BL (2017) Exploiting virus-like particles as innovative vaccines against emerging viral infections. J Microbiol 55(3):220–230
Pouyanfard S, Müller M (2017) Human papillomavirus first and second generation vaccines – current status and future directions. Biol Chem 398(8):871–889. https://doi.org/10.1515/hsz-2017-0105
Zaykov AN, Mayer JP, DiMarchi RD (2016) Pursuit of a perfect insulin. Nat Rev Drug Discov 15(6):425–439
Jia B, Jeon CO (2016) High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives. Open Biol 6(8). pii: 160196
Angius F, Ilioaia O, Uzan M, Miroux B (2016) Membrane protein production in Escherichia coli: protocols and rules. Methods Mol Biol 1432:37–52
Vincentelli R, Romier C (2016) Complex reconstitution and characterization by combining co-expression techniques in Escherichia coli with high-throughput. Adv Exp Med Biol 896:43–58
Vincentelli R, Romier C (2013) Expression in Escherichia coli: becoming faster and more complex. Curr Opin Struct Biol 23(3):326–334
Nettleship JE, Assenberg R, Diprose JM, Rahman-Huq N, Owens RJ (2010) Recent advances in the production of proteins in insect and mammalian cells for structural biology. J Struct Biol 172:55–65
Nettleship JE, Watson PJ, Rahman-Huq N, Fairall L, Posner MG, Upadhyay A, Reddivari Y, Chamberlain JM, Kolstoe SE, Bagby S, Schwabe JW, Owens RJ (2015) Transient expression in HEK 293 cells: an alternative to E. coli for the production of secreted and intracellular mammalian proteins. Methods Mol Biol 1258:209–222
Nie Y, Viola C, Bieniossek C, Trowitzsch S, Vijay-achandran LS, Chaillet M, Garzoni F, Berger I (2009) Getting a grip on complexes. Curr Genomics 10:558–572
Vijayachandran LS, Viola C, Garzoni F, Trowitzsch S, Bieniossek C, Chaillet M, Schaffitzel C, Busso D, Romier C, Poterszman A et al (2011) Robots, pipelines, polyproteins: enabling multiprotein expression in prokaryotic and eukaryotic cells. J Struct Biol 175:198–208
Nie Y, Chaillet M, Becke C, Haffke M, Pelosse M, Fitzgerald D, Collinson I, Schaffitzel C, Berger I (2016) ACEMBL tool-kits for high-throughput multigene delivery and expression in prokaryotic and eukaryotic hosts. Adv Exp Med Biol 896:27–42
Berger I, Fitzgerald DJ, Richmond TJ (2004) Baculovirus expression system for heterologous multiprotein complexes. Nat Biotechnol 22(12):1583–1587
Fitzgerald DJ, Berger P, Schaffitzel C, Yamada K, Richmond TJ, Berger I (2006) Protein complex expression by using multigene baculoviral vectors. Nat Methods 3(12):1021–1032
Bieniossek C, Richmond TJ, Berger I (2008) MultiBac: multigene baculovirus-based eukaryotic protein complex production. Curr Protoc Protein Sci Chapter 5:Unit 5.20
Trowitzsch S, Bieniossek C, Nie Y, Garzoni F, Berger I (2010) New baculovirus expression tools for recombinant protein complex production. J Struct Biol 172(1):45–54
Bieniossek C, Imasaki T, Takagi Y, Berger I (2012) MultiBac: expanding the research toolbox for multiprotein complexes. Trends Biochem Sci 37(2):49–57
Trowitzsch S, Palmberger D, Fitzgerald DJ, Takagi Y, Berger I (2012) MultiBac complexomics. Expert Rev Proteomics 9(4):363–373
Barford D, Takagi Y, Schultz P, Berger I (2013) Baculovirus expression: tackling the complexity challenge. Curr Opin Struct Biol 23(3):357–364
Berger I, Garzoni F, Chaillet M, Haffke M, Gupta K, Aubert A (2013) The MultiBac protein complex production platform at the EMBL. J Vis Exp 11(77):e50159
Sari D, Gupta K, Thimiri Govinda Raj DB, Aubert A, Drncová P, Garzoni F, Fitzgerald DJ, Berger I (2016) The MultiBac baculovirus/insect cell expression vector system for producing complex protein biologics. Adv Exp Med Biol 896:199–215
Palmberger D, Rendic D (2015) SweetBac: applying MultiBac technology towards flexible modification of insect cell glycosylation. Methods Mol Biol 1321:153–169
Palmberger D, Klausberger M, Berger I, Grabherr R (2013) MultiBac turns sweet. Bioengineered 4(2):78–83
Palmberger D, Wilson IB, Berger I, Grabherr R, Rendic D (2012) SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells. PLoS One 7(4):e34226
Fitzgerald DJ, Schaffitzel C, Berger P, Wellinger R, Bieniossek C, Richmond TJ, Berger I (2007) Multiprotein expression strategy for structural biology of eukaryotic complexes. Structure 15(3):275–279
Koehler C, Sauter PF, Wawryszyn M, Girona GE, Gupta K, Landry JJ, Fritz MH, Radic K, Hoffmann JE, Chen ZA et al (2016) Genetic code expansion for multiprotein complex engineering. Nat Methods 13(12):997–1000
Bahrami S, Laska MJ, Pedersen FS, Duch M (2016) Immune suppressive activity of the influenza fusion peptide. Virus Res 211:126–131
Holm CH, Jensen SB, Jakobsen MR, Cheshenko N, Horan KA, Moeller HB, Gonzalez-Dosal R, Rasmussen SB, Christensen MH, Yarovinsky TO et al (2012) Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat Immunol 13(8):737–743
Haffke M, Viola C, Nie Y, Berger I (2013) Tandem recombineering by SLIC cloning and Cre-LoxP fusion to generate multigene expression constructs for protein complex research. Methods Mol Biol 1073:131–140
Casini A, Storch M, Baldwin GS, Ellis T (2015) Bricks and blueprints: methods and standards for DNA assembly. Nat Rev Mol Cell Biol 16(9):568–576
Celie PH, Parret AH, Perrakis A (2016) Recombinant cloning strategies for protein expression. Curr Opin Struct Biol 38:145–154
Benoit RM, Ostermeier C, Geiser M, Li JS, Widmer H, Auer M (2016) Seamless insert-plasmid assembly at high efficiency and low cost. PLoS One 11(4):e0153158
Metcalf WW, Jiang W, Wanner BL (1994) Use of the rep technique for allele replacement to construct new Escherichia coli hosts for maintenance of R6Kλ origin plasmids at different copy numbers. Gene 138:1–7
Monteiro F, Bernal V, Chaillet M, Berger I, Alves PM (2016) Targeted supplementation design for improved production and quality of enveloped viral particles in insect cell-baculovirus expression system. J Biotechnol 233:34–41
Acknowledgements
We thank all members of the Berger and Schaffitzel laboratories for helpful discussions, as well as Rob Ruigrok, Thibaut Crepin, and Darren Hart for expert insight in influenza biology. We are grateful to Karin Huard for assistance with gradient preparation, and Yan Nie for introduction to negative-stain EM. This work was supported by the European Commission Framework Programme 7 projects ComplexINC (contract nr. 279039) and SynSignal (contract nr. 613879).
Competing Financial Interest Statement
The authors declare competing financial interest. Parts of the technology here described are subject of international patent EP2403940 and licensed exclusively to Geneva Biotech SARL.
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sari-Ak, D. et al. (2019). High-Throughput Production of Influenza Virus-Like Particle (VLP) Array by Using VLP-factory™, a MultiBac Baculoviral Genome Customized for Enveloped VLP Expression. In: Vincentelli, R. (eds) High-Throughput Protein Production and Purification. Methods in Molecular Biology, vol 2025. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9624-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9624-7_10
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9623-0
Online ISBN: 978-1-4939-9624-7
eBook Packages: Springer Protocols